OVID: Ovid Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 81.66
Enterprise Value ($M) 66.64
Book Value ($M) 76.29
Book Value / Share 1.07
Price / Book 1.07
NCAV ($M) 39.46
NCAV / Share 0.56
Price / NCAV 2.07

Profitability (mra)
Return on Invested Capital (ROIC) -0.36
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 5.66
Current Ratio 5.66

Balance Sheet (mrq) ($M)
Current Assets 65.83
Assets 102.65
Liabilities 26.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2 days ago 13G/A Biotechnology Value Fund L P 5.40 -43.75
2 days ago 13G/A EcoR1 Capital, LLC 0.00 -100.00
02-14 13G/A Madison Avenue Partners, LP 5.20 1.09
02-14 13G/A Levin Jeremy M 9.40 -4.66
02-12 13G/A Rubric Capital Management LP 7.52 -22.15
01-29 13G BlackRock, Inc. 6.10 259.18

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 127,541 399,445 31.93
2024-11-14 43,962 117,353 37.46
2024-11-13 182,102 365,886 49.77
2024-11-12 42,458 171,540 24.75
2024-11-11 194,527 855,557 22.74

(click for more detail)

Similar Companies
OPK – OPKO Health, Inc. OPTN – OptiNose, Inc.
ORIC – ORIC Pharmaceuticals, Inc. PASG – Passage Bio, Inc.
PBYI – Puma Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io